Clinical trial

Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease Inhibitor (PI) Or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) In HIV-1 Infected Adults

NCT00449436

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-01-10

PhasePHASE4

Study timeline

Study start (actual)2005-01-10Date precision: day

Registry last updated2018-10-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionsunresolved

Interventions

TRIZIVIRDRUG · verified · RxNorm: Trizivir

Non-nucleoside reverse transcriptase inhibitorDRUG

Boosted Protease InhibitorDRUG

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00449436 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.